HOME >> BIOLOGY >> NEWS
Wound monitor 'sniffs out' infections

The University of Manchester has received 1m (1.67m) to develop a new device able to 'sniff out' harmful infections.

The funding will be used to create a non-invasive wound monitor to treat patients with severe burns, skin ulcers or gaping wounds.

The aim is to produce a device which is able to detect harmful bacteria in the air, which may signal the first signs of infection. When bacteria metabolises inside a wound molecules of that bacteria are emitted into the air.

Current methods rely on medical staff taking swabs from a wound and testing them in a lab, which can take several days.

Professor Krishna Persaud, of The University of Manchester's School of Chemical Engineering and Analytical Science, who will coordinate the European-wide project, said: "Current methods make it difficult to detect infections at an early stage and can be extremely invasive causing the patient a great deal of discomfort".

"Our aim is to produce a non-invasive system that can monitor the state of a patient's wounds simply by detecting bad bacteria in the air emitted from the wound. Using state of the sensors we will be able to detect and diagnose the presence of an infection almost instantaneously."

The device will use new hybrid sensor technology with a mobile laboratory-based multi-technology gas sensor array and pattern recognition system, enabling the rapid analyses of molecules in the air. It is envisaged that the monitor will be take the form of a mobile unit which sits alongside other monitoring equipment next to the patient.

Key applications for the device will include monitoring trauma injuries, chronic ulcers and in military field hospitals.

Manchester will coordinate a European team of engineers and medical experts, which will include consultants from the Department of Burns and Plastic Surgery at Wythenshawe Hospital (Manchester) and Kaunas Medical University Hospital (Lithuania). The three year project is funde
'"/>

Contact: Simon Hunter
simon.hunter@manchester.ac.uk
161-275-8387
University of Manchester
14-Mar-2006


Page: 1 2

Related biology news :

1. Wound botulism
2. Wounds may one day heal better, faster, due to new NIH-funded wound healing centers
3. Who needs environmental monitoring?
4. DNA repair proteins monitored at double-strand break
5. Marine scientists monitor longest mammal migration
6. Snowmelt monitored in the Baltic Sea watershed region in near real time
7. Want to monitor climate change? P-p-p-pick up a penguin!
8. Researchers urge monitoring of bone health during chemotherapy
9. New study shows promise of toxicogenomics in environmental monitoring
10. CellSearch System cleared for monitoring metastatic breast cancer
11. Magic marker monitors malicious movements

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Wound monitor sniffs out infections

(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying ... power and potential for genomic science as a means ... disease prevention and treatment.  I was honored to participate ... government-funded precision medicine program. Since the ... science of genomics—from the first sequenced genome of a ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the ... report to their offering. , The ... individual is who she/he is claiming to be, and for ... unique physical characteristics, such as fingerprint, hand or palm print, ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
(Date:3/3/2015)... Experts and industry insiders from around the ... Alltech REBELation exploring innovation, inspiration and world-changing ideas in ... 31st year, Alltech’s annual international conference traditionally draws more ... to join the REBELation at an extra discount registration ... at which point the standard early registration rate will ...
(Date:3/3/2015)... 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), a life sciences ... products for advanced microarray diagnostics, today announced it ... its Management team. In his capacity as CFO ... from a development stage to a commercially successful ... Company,s capital market strategy and to secure funding ...
(Date:3/3/2015)... 3, 2015  Regenicin, Inc. (OTC Bulletin Board: ... development of and commercialization of regenerative cell therapies to ... today that it has received the final payment to ... Inc. (OTC Bulletin Board: AMBS ). ... the final payments due to Regenicin in the amount ...
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  RegeneRx ... an editorial in the scientific journal, Expert Opinion ... and his colleague, Dr. Zhenggang Zhang , at ... reported that Thymosin beta 4 (TB4) has ... (PNS) remodeling 24 hours or more post-injury, leading to ...
Breaking Biology Technology:World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
Cached News: